Miguel Forte
Miguel Forte is Chief Executive Officer, Zelluna Immunotherapy and Chief Commercialization Officer and Chair of Commercialization Committee, International Society for Cell and Gene Therapy (ISCT).
Now for the High-Hanging Fruit
January 22, 2019
We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface of what’s possible.
0 min read
The TCRs Are Coming
December 14, 2019
It’s time to fine-tune the way we target solid tumors
1 min read
Advanced Medicines: Making it to Market
August 19, 2019
We’ve learned a number of lessons when it comes to developing and manufacturing cell therapies, including the importance of keeping our eyes on the end goal of commercial manufacturing – even at the earliest stages.
1 min read
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
